Crossject S.A [ALCJ] vs Spineway S.A [ALSPW] Detailed Stock Comparison

Crossject S.A.

EURONEXT
Loading...

Spineway S.A.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Crossject S.A. wins in 4 metrics, Spineway S.A. wins in 8 metrics, with 1 ties. Spineway S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Crossject S.A. Spineway S.A. Better
P/E Ratio (TTM) N/A 16.20 N/A
Price-to-Book Ratio N/A 0.25 N/A
Debt-to-Equity Ratio -4.61 6.63 Spineway S.A.
PEG Ratio 3.48 -2.31 Crossject S.A.
EV/EBITDA 0.00 -2.78 Tie
Profit Margin (TTM) 0.00% -17.47% Crossject S.A.
Operating Margin (TTM) -630.31% -13.23% Spineway S.A.
Return on Equity 212.74% -9.46% Crossject S.A.
Return on Assets (TTM) -23.40% -4.45% Spineway S.A.
Free Cash Flow (TTM) $-10.85M $-3.27M Spineway S.A.
1-Year Return 6.04% -25.00% Crossject S.A.
Price-to-Sales Ratio (TTM) 41.73 0.45 Spineway S.A.
Enterprise Value $0 $3.79M Spineway S.A.
EV/Revenue Ratio N/A 0.30 N/A
Revenue per Share (TTM) N/A $0 N/A
Earnings per Share (Diluted) $-0.20 $0.01 Spineway S.A.
Beta (Stock Volatility) 0.52 0.19 Spineway S.A.

Crossject S.A. vs Spineway S.A. Stock Performance Analysis

Loading Price Chart...

ALCJ
ALSPW

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Crossject S.A.-0.31%1.05%1.05%-3.98%-7.21%-9.81%
Spineway S.A.0.32%-7.69%-14.29%-25.00%-25.00%-25.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Crossject S.A.6.04%-50.89%-39.31%-72.74%-83.28%-83.28%
Spineway S.A.-25.00%-25.00%-25.00%-25.00%-25.00%-25.00%

Performance & Financial Health Analysis: Crossject S.A. vs Spineway S.A.

MetricALCJALSPW
Market Information
Market Cap i€105.59M€5.76M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i183,082161,971
90 Day Avg. Volume i240,224119,807
Last Close€1.93€0.12
52 Week Range€1.35 - €2.69€0.10 - €0.26
% from 52W High-28.53%-51.56%
All-Time High€13.09 (Feb 24, 2014)€0.22 (Oct 15, 2025)
% from All-Time High-85.26%-45.45%
Growth Metrics
Quarterly Revenue Growth-0.60%0.17%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.00%-0.17%
Operating Margin (TTM) i-6.30%-0.13%
Return on Equity (TTM) i2.13%-0.09%
Debt to Equity (MRQ) i-4.616.63
Cash & Liquidity
Book Value per Share (MRQ)€-0.02€0.65
Cash per Share (MRQ)N/A€0.10
Operating Cash Flow (TTM) i€-6,348,050€-163,000
Levered Free Cash Flow (TTM) i€-9,610,150€49,750
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Crossject S.A. vs Spineway S.A.

MetricALCJ (Apr 24, 2026)ALSPW (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A16.20
Forward P/E i3.48-2.31
PEG Ratio i3.48-2.31
Price to Sales (TTM) i41.730.45
Price to Book (MRQ) iN/A0.25
Market Capitalization
Market Capitalization i€105.59M€5.76M
Enterprise Value i€0€3.79M
Enterprise Value Metrics
Enterprise to Revenue iN/A0.30
Enterprise to EBITDA i0.00-2.78
Risk & Other Metrics
Beta i0.520.19
Book Value per Share (MRQ) i€-0.02€0.65

Financial Statements Comparison: Crossject S.A. vs Spineway S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALCJ (2025)ALSPW (2024)
Revenue/Sales i011.95M
Cost of Goods Sold i9.71M3.50M
COGS % of Revenue i-29.3%
Gross Profit i-9.71M8.45M
Gross Margin i-70.7%
Research & Development iN/AN/A
Operating Income (EBIT) i-11.61M-885,000
Operating Margin i--7.4%
EBITDA i-5.91M-1.11M
EBITDA Margin i--9.3%
Pre-Tax Income i-13.18M-3.86M
Pre-Tax Income % of Revenue i--32.3%
Income Tax i-2.82MN/A
Income Tax % of Revenue i-0.0%
Net Income (Profit) i-10.37M-3.87M
Profit Margin i--32.3%

Balance Sheet & Liquidity Metrics

MetricALCJ (2025)ALSPW (2024)
Cash & Equivalents i5.08M4.52M
Total Current Assets i15.43M13.89M
Total Current Assets % of Revenue i-116.3%
Total Current Liabilities i6.56M4.23M
Total Current Liabilities % of Revenue i-35.4%
Long-Term Debt i19.82M1.66M
Long-Term Debt % of Revenue i-13.9%
Total Shareholders Equity i-4.87M24.24M
Retained Earnings i-18.76M-3.87M
Retained Earnings % of Revenue i--32.3%
Property, Plant & Equipment i2.43M5.93M

Cash Flow Statement Comparison

MetricALCJ (2025)ALSPW (2024)
Operating Cash Flow i-10.35M-3.87M
Operating Cash Flow % of Revenue i--32.3%
Capital Expenditures i-4.46MN/A
Free Cash Flow i-10.85M-3.27M
FCF Margin i--27.4%
Debt Repayment i-3.50MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricALCJALSPW
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i52.19M35.54M
Float Shares iN/AN/A
% Held by Insiders i23.91%0.00%
% Held by Institutions i0.31%0.00%
% Held by Public i75.78%100.00%

Dividend Analysis & Yield Comparison: Crossject S.A. vs Spineway S.A.

MetricALCJALSPW
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A